TapewireFind a company

person · Reporting owner

Volkart Carmen B

Disclosed activity across 3 companies

Tapewire entity
33183
SEC CIK
0001282953

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Modular Medical, Inc.MODD · Entity 7488DirectorSeptember 30, 2026October 02, 2026
TACTILE SYSTEMS TECHNOLOGY INCTCMD · Entity 5451DirectorMay 06, 2026May 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Modular Medical, Inc.

Report date September 30, 2026 · Filed October 02, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect1,036 Reported balance After 2026-09-30 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-09-30 · Grant · Acquired 108 · Balance 1,036

F1: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

F2: Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

F2: Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

TACTILE SYSTEMS TECHNOLOGY INC

Report date May 06, 2026 · Filed May 08, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect44,219 Reported balance After 2026-05-06 transaction · row 1
1 source row

Row 1 · 2026-05-06 · Grant · Acquired 6,521 · Balance 44,219

F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ANTARES PHARMA, INC.

Report date May 24, 2022 · Filed May 26, 2022

Section 16 reporting ended · disclosed 2022-05-26. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.48Direct0 Reported balance After 2022-05-24 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2022-05-24 · Disposition to issuer · Disposed 55,916 · Balance 0

F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 12, 2022, by and among the Issuer, Antares Pharma, Inc., a Delaware corporation (the "Company"), Halozyme Therapeutics, Inc., a Delaware corporation ("Parent"), and Atlas Merger Sub, Inc., a Delaware corporation ("Purchaser") and a wholly owned subsidiary of Parent, to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.01 par value per share (each, a "Share") and thereafter merged with and into the Issuer (the "Merger") effective as of May 24, 2022 (the "Effective Time").

F2: (Continued from Footnote 1) At the Effective Time, each Share outstanding immediately prior to the Effective Time (other than Excluded Shares) was converted into the right to receive $5.60 in cash, without interest (the "Merger Consideration") and subject to any withholding of taxes required by applicable legal requirements, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled.

F3: Each Company option to purchase Shares ("Company Option") means any option to purchase Shares granted under the Company Equity Plan. At the Effective Time, each Company Option that was then outstanding as of immediately prior to the Effective Time was, to the extent unvested, accelerated and became fully vested and exercisable effective prior to the Effective Time. Each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of Shares subject to such Company Option immediately prior to the Effective Time, multiplied by (ii) the excess of (A) the Merger Consideration over (B) the exercise price payable per Share under such Company Option.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 12, 2022, by and among the Issuer, Antares Pharma, Inc., a Delaware corporation (the "Company"), Halozyme Therapeutics, Inc., a Delaware corporation ("Parent"), and Atlas Merger Sub, Inc., a Delaware corporation ("Purchaser") and a wholly owned subsidiary of Parent, to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.01 par value per share (each, a "Share") and thereafter merged with and into the Issuer (the "Merger") effective as of May 24, 2022 (the "Effective Time").

F2: (Continued from Footnote 1) At the Effective Time, each Share outstanding immediately prior to the Effective Time (other than Excluded Shares) was converted into the right to receive $5.60 in cash, without interest (the "Merger Consideration") and subject to any withholding of taxes required by applicable legal requirements, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled.

F3: Each Company option to purchase Shares ("Company Option") means any option to purchase Shares granted under the Company Equity Plan. At the Effective Time, each Company Option that was then outstanding as of immediately prior to the Effective Time was, to the extent unvested, accelerated and became fully vested and exercisable effective prior to the Effective Time. Each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of Shares subject to such Company Option immediately prior to the Effective Time, multiplied by (ii) the excess of (A) the Merger Consideration over (B) the exercise price payable per Share under such Company Option.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2026 Filed Oct 2, 2026 02:26 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 108 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-105960 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,036

F1 · price: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

F2 · balance_after: Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:30 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 110 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-075011 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 916

F1 · price: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

F2 · balance_after: Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

Read SEC document
May 06, 2026 Filed May 8, 2026 21:29 UTC TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 GrantCommon Stock 6,521 $0.00 $0.00
Disclosure

SEC source: 0001282953-26-000002 · form4-05082026_090506.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,219

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
March 31, 2026 Filed Apr 8, 2026 21:00 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 103 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-041554 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 806

F1 · price: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

F2 · balance_after: Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

Read SEC document
December 31, 2025 Filed Jan 6, 2026 00:05 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 3,125 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-001366 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,460

F1 · price: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

Read SEC document
September 30, 2025 Filed Oct 3, 2025 00:30 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 3,125 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-095744 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,335

F1 · price: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

Read SEC document
June 30, 2025 Filed Jul 2, 2025 10:01 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 3,125 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-060671 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,210

F1 · price: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

Read SEC document
May 07, 2025 Filed May 9, 2025 20:26 UTC TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 GrantCommon Stock 16,078 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-015795 · rdgdoc.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,698

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
March 31, 2025 Filed Apr 1, 2025 21:00 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.10 Not disclosed
Disclosure

SEC source: 0001213900-25-027223 · ownership.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2035-03-31

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
March 31, 2025 Filed Apr 1, 2025 21:00 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 625 $1.10 $687.50
Disclosure

SEC source: 0001213900-25-027223 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,085

F1 · security: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

Read SEC document
December 31, 2024 Filed Jan 3, 2025 21:00 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.39 Not disclosed
Disclosure

SEC source: 0001213900-25-000733 · ownership.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-12-31

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
December 31, 2024 Filed Jan 3, 2025 21:00 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 625 $1.39 $868.75
Disclosure

SEC source: 0001213900-25-000733 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,460

F1 · security: These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 10:16 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $2.28 Not disclosed
Disclosure

SEC source: 0001213900-24-084297 · ownership.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-09-30

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
September 30, 2024 Filed Oct 2, 2024 10:16 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 625 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-084297 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,835

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 21:54 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.56 Not disclosed
Disclosure

SEC source: 0001213900-24-058703 · ownership.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-06-30

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
June 28, 2024 Filed Jul 2, 2024 21:54 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 625 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-058703 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,210

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:20 UTC TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 GrantCommon Stock 10,469 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-016019 · rdgdoc.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,620

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
March 31, 2024 Filed Apr 3, 2024 01:34 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.95 Not disclosed
Disclosure

SEC source: 0001213900-24-029545 · ownership.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-03-31

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
March 29, 2024 Filed Apr 3, 2024 01:34 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 625 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-029545 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,585

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 00:11 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.78 Not disclosed
Disclosure

SEC source: 0001213900-24-000364 · ownership.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2033-12-29

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
December 29, 2023 Filed Jan 3, 2024 00:11 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 625 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-000364 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,960

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
September 30, 2023 Filed Oct 3, 2023 10:03 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $1.16 Not disclosed
Disclosure

SEC source: 0001013762-23-000707 · ownership.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2033-09-30

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
September 30, 2023 Filed Oct 3, 2023 10:03 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 625 Not disclosed Not disclosed
Disclosure

SEC source: 0001013762-23-000707 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,335

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 21:30 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001213900-23-054869 · ownership.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2033-06-30

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · price: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
June 30, 2023 Filed Jul 5, 2023 21:30 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 625 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-23-054869 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,710

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
May 08, 2023 Filed May 10, 2023 20:22 UTC TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 GrantCommon Stock 7,737 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-013617 · rdgdoc.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,151

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
March 31, 2023 Filed Apr 3, 2023 19:38 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 $1.44 Strike: $1.44 $10,800.00
Disclosure

SEC source: 0001213900-23-026205 · ownership.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2033-03-31

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
March 31, 2023 Filed Apr 3, 2023 19:38 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 625 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-23-026205 · ownership.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,085

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
February 22, 2023 Filed Feb 24, 2023 21:43 UTC TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 GrantCommon Stock 3,414 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-004566 · rdgdoc.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,414

F1 · shares: Represents restricted stock units that will vest in full on the date of the annual meeting of stockholders in 2023.

Read SEC document
December 31, 2022 Filed Jan 3, 2023 21:36 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 $2.14 Strike: $2.14 $16,050.00
Disclosure

SEC source: 0001019056-23-000011 · volkart.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2032-12-31

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
December 30, 2022 Filed Jan 3, 2023 21:36 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 625 Not disclosed Not disclosed
Disclosure

SEC source: 0001019056-23-000011 · volkart.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,460

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
September 30, 2022 Filed Oct 3, 2022 18:53 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 $4.34 Strike: $4.34 $32,550.00
Disclosure

SEC source: 0001019056-22-000616 · volkart.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2032-09-30

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
September 30, 2022 Filed Oct 3, 2022 18:53 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 625 Not disclosed Not disclosed
Disclosure

SEC source: 0001019056-22-000616 · volkart.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,835

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
July 19, 2022 Filed Aug 8, 2022 20:22 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 7,500 $5.16 Strike: $5.16 $38,700.00
Disclosure

SEC source: 0001019056-22-000547 · volkart.xml · derivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2032-07-19

F1 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Read SEC document
June 30, 2022 Filed Jul 5, 2022 16:12 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 1,211 Not disclosed Not disclosed
Disclosure

SEC source: 0001019056-22-000495 · volkart.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,210

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
May 24, 2022 Filed May 26, 2022 17:23 UTC ANTARES PHARMA, INC. ATRS · Entity 126887 Disposition to issuerStock Option (right to buy) · Derivative 55,916 Not disclosed Strike: $3.48 Not disclosed
Disclosure

SEC source: 0000899243-22-019782 · doc4.xml · derivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 55,916 shares

Expires not disclosed

F1 · security: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 12, 2022, by and among the Issuer, Antares Pharma, Inc., a Delaware corporation (the "Company"), Halozyme Therapeutics, Inc., a Delaware corporation ("Parent"), and Atlas Merger Sub, Inc., a Delaware corporation ("Purchaser") and a wholly owned subsidiary of Parent, to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.01 par value per share (each, a "Share") and thereafter merged with and into the Issuer (the "Merger") effective as of May 24, 2022 (the "Effective Time").

F2 · security: (Continued from Footnote 1) At the Effective Time, each Share outstanding immediately prior to the Effective Time (other than Excluded Shares) was converted into the right to receive $5.60 in cash, without interest (the "Merger Consideration") and subject to any withholding of taxes required by applicable legal requirements, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled.

F3 · price: Each Company option to purchase Shares ("Company Option") means any option to purchase Shares granted under the Company Equity Plan. At the Effective Time, each Company Option that was then outstanding as of immediately prior to the Effective Time was, to the extent unvested, accelerated and became fully vested and exercisable effective prior to the Effective Time. Each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of Shares subject to such Company Option immediately prior to the Effective Time, multiplied by (ii) the excess of (A) the Merger Consideration over (B) the exercise price payable per Share under such Company Option.

F3 · derivative.exercise_date: Each Company option to purchase Shares ("Company Option") means any option to purchase Shares granted under the Company Equity Plan. At the Effective Time, each Company Option that was then outstanding as of immediately prior to the Effective Time was, to the extent unvested, accelerated and became fully vested and exercisable effective prior to the Effective Time. Each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of Shares subject to such Company Option immediately prior to the Effective Time, multiplied by (ii) the excess of (A) the Merger Consideration over (B) the exercise price payable per Share under such Company Option.

F3 · derivative.expiration_date: Each Company option to purchase Shares ("Company Option") means any option to purchase Shares granted under the Company Equity Plan. At the Effective Time, each Company Option that was then outstanding as of immediately prior to the Effective Time was, to the extent unvested, accelerated and became fully vested and exercisable effective prior to the Effective Time. Each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of Shares subject to such Company Option immediately prior to the Effective Time, multiplied by (ii) the excess of (A) the Merger Consideration over (B) the exercise price payable per Share under such Company Option.

Read SEC document
March 31, 2022 Filed Apr 4, 2022 21:02 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 17,943 $4.18 Strike: $4.18 $75,001.74
Disclosure

SEC source: 0001019056-22-000314 · volkart.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,943

Underlying: Common Stock · 17,943 shares

Expires 2032-03-31

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grant reported herein, the Reporting Person currently has aggregate options to purchase a total of 90,557 shares of the Issuer.

Read SEC document
March 31, 2022 Filed Apr 4, 2022 21:02 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 1,737 Not disclosed Not disclosed
Disclosure

SEC source: 0001019056-22-000314 · volkart.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,999

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
December 31, 2021 Filed Jan 3, 2022 11:06 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 9,987 $7.51 Strike: $7.51 $75,002.37
Disclosure

SEC source: 0001019056-22-000010 · volkart.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,987

Underlying: Common Stock · 9,987 shares

Expires 2031-12-31

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grant reported herein, the Reporting Person currently has aggregate options to purchase a total of 72,614 shares of the Issuer.

Read SEC document
December 31, 2021 Filed Jan 3, 2022 11:06 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 999 Not disclosed Not disclosed
Disclosure

SEC source: 0001019056-22-000010 · volkart.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,262

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
October 27, 2021 Filed Oct 29, 2021 18:14 UTC ANTARES PHARMA, INC. ATRS · Entity 126887 GrantStock Option (right to buy) · Derivative 55,916 $0.00 Strike: $3.48 $0.00
Disclosure

SEC source: 0001016169-21-000028 · wf-form4_163554564976041.xml · derivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,916

Underlying: Common Stock · 55,916 shares

Expires 2031-10-27

F1 · shares: Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 17:30 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 25,168 $2.98 Strike: $2.98 $75,000.64
Disclosure

SEC source: 0001019056-21-000523 · volkart.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,168

Underlying: Common Stock · 25,168 shares

Expires 2031-09-30

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grant reported herein, the Reporting Person currently has aggregate options to purchase a total of 187,880 shares of the Issuer.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 17:30 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 2,517 Not disclosed Not disclosed
Disclosure

SEC source: 0001019056-21-000523 · volkart.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,788

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 19:39 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 12,712 $5.90 Strike: $5.90 $75,000.80
Disclosure

SEC source: 0001019056-21-000406 · volkart.xml · derivative · entry 2

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,712

Underlying: Common Stock · 12,712 shares

Expires 2031-06-30

F2 · security: The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

F3 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grant reported herein, the Reporting Person currently has aggregate options to purchase a total of 162,712 shares of the Issuer.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 19:39 UTC Modular Medical, Inc. MODD · Entity 7488 GrantCommon Stock 1,271 Not disclosed Not disclosed
Disclosure

SEC source: 0001019056-21-000406 · volkart.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,271

F1 · price: The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.

Read SEC document
January 23, 2020 Filed Jan 27, 2020 18:09 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 60,000 $2.25 Strike: $2.25 $135,000.00
Disclosure

SEC source: 0001019056-20-000035 · volkart.xml · derivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 60,000 shares

Expires 2030-01-23

F1 · security: This option will vest as to one-third of the shares subject to the option on each annual anniversary of December 31, 2019.

Read SEC document
December 31, 2019 Filed Jan 27, 2020 18:08 UTC Modular Medical, Inc. MODD · Entity 7488 GrantOption to purchase common stock · Derivative 90,000 $2.25 Strike: $2.25 $202,500.00
Disclosure

SEC source: 0001019056-20-000033 · volkart.xml · derivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2029-12-31

F1 · security: This option will vest as to one-third of the shares subject to the option on each annual anniversary of December 31, 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.